Emily R. Mackler, PharmD, BCOP, Oncology Clinical Pharmacist, Michigan Oncology Quality Consortium at the University of Michigan Comprehensive Cancer Center, and Adjunct Clinical Associate Professor at the University of Michigan College of Pharmacy, Ann Arbor, discusses the clinical significance of her study, “Implementation of and Satisfaction with an Outpatient Oral Anticancer Therapy Program.”
Related Items
JHOP - October 2026 Vol 16, No 5 published on May 18, 2026 in Original Research, Adverse Events, Transplant, Drug Resistance, Oncology Pharmacy Programs/Protocols
JHOP - October 2026 Vol 16, No 5 published on May 12, 2026 in Original Research, Lymphoma, Methotrexate, Chemotherapy
JHOP - December 2026 Vol 16, No 6 published on April 20, 2026 in Original Research, Chemotherapy, Oncology Pharmacy Programs/Protocols, Supportive Care, Breast Cancer
JHOP - October 2026 Vol 16, No 5 published on March 23, 2026 in Original Research, Adverse Events, Disparities in Oncology Care, Dose Escalation/Reduction, Immunotherapy, Multiple Myeloma